• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clinical responses in human onchocerciasis: parasitological and immunological implications.

作者信息

Mackenzie C D, Williams J F, Guderian R H, O'Day J

出版信息

Ciba Found Symp. 1987;127:46-72. doi: 10.1002/9780470513446.ch5.

DOI:10.1002/9780470513446.ch5
PMID:3297560
Abstract

Onchocerciasis can cause severe dermal and ocular disease due, it is thought, to the events surrounding the destruction of the microfilarial stage. The evolution of papular pruritic dermatitis and punctate keratitis is clearly related to the killing of microfilariae. Other more chronic changes such as dermal and epidermal atrophy are probably due to repeated episodes of microfilarial killing. It is common to find that not all patients are, at any one time, mounting clinically obvious destructive host responses against the microfilariae, and such individuals can carry very high loads of parasites without any apparent adverse effects. The immunological basis of the differences between these types of patients forms one of the most important questions in the pathogenesis of onchocerciasis today. Various explanations are now emerging. These include immunosuppressive factors and variation in the form of Onchocerca volvulus antigens presented to the host. Clinical presentations of this disease appear to reflect variations in host responses and can be used to provide information concerning the protective immune responses an individual can mount against this parasite.

摘要

相似文献

1
Clinical responses in human onchocerciasis: parasitological and immunological implications.
Ciba Found Symp. 1987;127:46-72. doi: 10.1002/9780470513446.ch5.
2
Cutaneous pathology in onchocerciasis associated with pronounced systemic T-helper 2-type responses to Onchocerca volvulus.
Br J Dermatol. 2003 Oct;149(4):782-7. doi: 10.1046/j.1365-2133.2003.05556.x.
3
Variations in host responses and the pathogenesis of human onchocerciasis.人类盘尾丝虫病宿主反应的差异及发病机制。
Rev Infect Dis. 1985 Nov-Dec;7(6):802-8. doi: 10.1093/clinids/7.6.802.
4
Associations between clinical disease, circulating antibodies and C1q-binding immune complexes in human onchocerciasis.人体盘尾丝虫病中临床疾病、循环抗体与C1q结合免疫复合物之间的关联
Parasite Immunol. 1987 Jul;9(4):447-63. doi: 10.1111/j.1365-3024.1987.tb00522.x.
5
Cell adherence to microfilariae of Onchocerca volvulus: a comparative study.细胞对盘尾丝虫微丝蚴的黏附:一项比较研究。
Ciba Found Symp. 1987;127:146-63. doi: 10.1002/9780470513446.ch10.
6
Onchocerciasis: experimental models of ocular disease.
Rev Infect Dis. 1985 Nov-Dec;7(6):820-5. doi: 10.1093/clinids/7.6.820.
7
Immunopathology of onchocerciasis: a role for eosinophils in onchocercal dermatitis and keratitis.盘尾丝虫病的免疫病理学:嗜酸性粒细胞在盘尾丝虫性皮炎和角膜炎中的作用。
Chem Immunol. 1997;66:26-40. doi: 10.1159/000058664.
8
Onchocerciasis: clinical presentation and host parasite interactions in patients of southern Sudan.盘尾丝虫病:苏丹南部患者的临床表现及宿主与寄生虫的相互作用
Int J Dermatol. 1997 Jan;36(1):23-8. doi: 10.1046/j.1365-4362.1997.00007.x.
9
Severe onchocercal dermatitis in the Ethiopian border region of Sudan.苏丹埃塞俄比亚边境地区的严重盘尾丝虫性皮炎。
Ann Trop Med Parasitol. 1987 Aug;81(4):405-19. doi: 10.1080/00034983.1987.11812138.
10
The reduction in microfilariae loads in the skin and eye after nodulectomy in Ecuadorian onchocerciasis.厄瓜多尔盘尾丝虫病患者结节切除术后皮肤和眼部微丝蚴负荷的降低。
Trop Med Parasitol. 1987 Dec;38(4):275-8.

引用本文的文献

1
Whole blood transcriptome analysis in onchocerciasis.盘尾丝虫病的全血转录组分析
Curr Res Parasitol Vector Borne Dis. 2022 Aug 9;2:100100. doi: 10.1016/j.crpvbd.2022.100100. eCollection 2022.
2
Suppression of human lymphocyte responses to specific and non-specific stimuli in human onchocerciasis.人类盘尾丝虫病患者中人类淋巴细胞对特异性和非特异性刺激反应的抑制
Clin Exp Immunol. 1991 Dec;86(3):433-9. doi: 10.1111/j.1365-2249.1991.tb02949.x.